Soil acidification and the liming potential of biochar.

Soil acidification in managed ecosystems such as agricultural lands principally results from the increased releasing of protons (H+) from the transformation reactions of carbon (C), nitrogen (N) and sulphur (S) containing compounds. The incorporation of liming materials can neutralize the protons released, hence reducing soil acidity and its adverse impacts to the soil environment, food security, and human health. Biochar derived from organic residues is becoming a source of carbon input to soil and provides multifunctional values. Biochar can be alkaline in nature, with the level of alkalinity dependent upon the feedstock and processing conditions. This review covers the fundamental aspects of soil acidification and of the use of biochar to address constraints related to acidic soil. Biochar is increasingly considered as an effective soil amendment for reducing soil acidity owing to its liming potential, thereby enhancing soil fertility and productivity in acid soils. The ameliorant effect on acid soils is mainly because of the dissolution of carbonates, (hydro)-oxides of the ash fraction of biochar and potential use by microorganisms.

The emergence of nanoporous materials in lung cancer therapy.

Lung cancer is one of the most common cancers, affecting more than 2.1 million people across the globe every year. A very high occurrence and mortality rate of lung cancer have prompted active research in this area with both conventional and novel forms of therapies including the use of nanomaterials based drug delivery agents. Specifically, the unique physico-chemical and biological properties of porous nanomaterials have gained significant momentum as drug delivery agents for delivering a combination of drugs or merging diagnosis with targeted therapy for cancer treatment. This review focuses on the emergence of nano-porous materials for drug delivery in lung cancer. The review analyses the currently used nanoporous materials, including inorganic, organic and hybrid porous materials for delivering drugs for various types of therapies, including chemo, radio and phototherapy. It also analyses the selected research on stimuli-responsive nanoporous materials for drug delivery in lung cancer before summarizing the various findings and projecting the future of emerging trends. This review provides a strong foundation for the current status of the research on nanoporous materials, their limitations and the potential for improving their design to overcome the unique challenges of delivering drugs for the treatment of lung cancer.